Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly's Effient Tied in Study to Higher Rate of Cancer Risk Than Plavix
Lilly's Effient Tied in Study to Higher Rate of Cancer Risk Than Plavix
Lilly's Effient Tied in Study to Higher Rate of Cancer Risk Than Plavix
Submitted by
admin
on June 29, 2010 - 9:05am
Source:
Bloomberg
News Tags:
cancer
Effient
Eli Lilly
blood thinners
Plavix
Bristol-Myers Squibb
Headline:
Lilly's Effient Tied in Study to Higher Rate of Cancer Risk Than Plavix
Do Not Allow Advertisers to Use My Personal information
